Singapore markets close in 3 hours 53 minutes
Straits Times Index
3,307.52 +10.63 (+0.32%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,413.79 +206.66 (+1.14%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,548.67 +2,264.78 (+3.95%) CMC Crypto 200
1,282.88 +12.14 (+0.96%)
TriSalus Life Sciences, Inc. (TLSI)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 9.31 |
| Open | 9.31 |
| Bid | 9.32 x 100 |
| Ask | 0.00 x 0 |
| Day's range | 9.31 - 9.55 |
| 52-week range | 3.32 - 12.83 |
| Volume | |
| Avg. volume | 41,863 |
| Market cap | 281.118M |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.73 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 16.00 |
Business WireTriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
DENVER, April 30, 2024--TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced the closing of a debt financing facility for up to $50 million with OrbiMed, a healthcare investment firm. The capital is expected to provide financial flexibility to support the execution of strategic expansion plans and fuel continued growth.
GuruFocus.comTriSalus Life Sciences Inc (TLSI) Q4 and Full Year 2023 Earnings: Revenue Growth Amidst Late ...
TriSalus Surpasses Revenue Estimates but Faces Net Loss Wider Than Expected
Business WireTriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
DENVER & SALT LAKE CITY, April 01, 2024--TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced its financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.
© 2024 Yahoo. All rights reserved.